2017
DOI: 10.1186/s12939-017-0700-1
|View full text |Cite
|
Sign up to set email alerts
|

Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study

Abstract: BackgroundAcute rheumatic fever (ARF) rates have declined to near zero in nearly all developed countries. However, in New Zealand rates have not declined since the 1980s. Further, ARF diagnoses in New Zealand are inequitably distributed--occurring almost exclusively in Māori (the indigenous population) and Pacific children--with very low rates in the majority New Zealand European population. With ARF diagnosis, secondary prophylaxis is key to prevent recurrence. The purpose of this study was to identify the pe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(37 citation statements)
references
References 31 publications
(83 reference statements)
1
16
0
Order By: Relevance
“…It's in our family." Pregnant Aboriginal women quoted in Belton et al, 2016 [9] The New Zealand literature gave more depth to descriptions of the impacts of power differentials, describing a lack of trust, feeling judged, having to 'push' to have throat swabs taken and diagnostic failures even when family members suspected ARF [37,40,41].…”
Section: Experiences Of Power Differences and Racismmentioning
confidence: 99%
“…It's in our family." Pregnant Aboriginal women quoted in Belton et al, 2016 [9] The New Zealand literature gave more depth to descriptions of the impacts of power differentials, describing a lack of trust, feeling judged, having to 'push' to have throat swabs taken and diagnostic failures even when family members suspected ARF [37,40,41].…”
Section: Experiences Of Power Differences and Racismmentioning
confidence: 99%
“…The well-documented disparities in health outcomes for racial groups in some societies, even when socioeconomic status is taken into account, have been attributed to institutional racism in many studies. [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] A recent critique of the development of racism theory over the preceding 50 years contends that the opportunity to elaborate an overarching theory of racism with cultural, institutional and individual levels has been lost with today's theoretical offerings only providing 'one-dimensional and reductionist explanations of race relations'. 18(p574) Regardless of this lack of strategic theory development, the diverse literature covers key questions relevant to health care about institutional racism including: is it caused by the personal racism of individual employees or the processes, structure and governance of an organisation; is it a deliberate action or inaction of society or its key organisations; can it be applied to individual organisations or is it a total societal condition; how does institutional racism deliver healthcare discrepancies; and how does resistance to eliminating institutional racism manifest?…”
Section: What Is Institutional Racism?mentioning
confidence: 99%
“…There is an inevitable potential for systematic reviews to become outdated rapidly with the publication of new studies. Since the publication of the review by Kevat et al ., more than ten additional pertinent studies have been published, from Australia [ 11 - 13 ], Egypt [ 14 ], Fiji [ 15 , 16 ], India [ 17 ], Jamaica [ 18 ], New Zealand [ 19 , 20 ], Uganda [ 21 ] and Zambia [ 22 ].…”
Section: Commentmentioning
confidence: 99%
“…Firstly, the findings underscore that the determinants of effective SP implementation arise at the interface of health systems and the patient milieu. Examples of factors repeatedly identified as influencing adherence include geographic remoteness and physical distance to health facilities vis-à-vis transport options [ 15 , 18 , 23 , 24 ], inconvenience to patients exacerbated by competing priorities (such as schooling or employment) and clinic wait times [ 14 , 18 ], the quality of provider-patient relationships and communications [ 23 , 25 - 27 ], fear of painful injections [ 18 , 19 , 28 ], the degree of education and disease awareness among patients (or, in the case of children, their parents) [ 14 , 19 , 27 , 28 ], and levels of support from family and friends [ 24 , 25 ].…”
Section: Commentmentioning
confidence: 99%